Total Payments
$51,325
2024 Payments
$5,183
Companies
82
Transactions
1,956
Medicare Patients
7,046
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$27,768 (54.1%)
Other$21,836 (42.5%)
Research$672.91 (1.3%)
Travel$559.94 (1.1%)
Education$488.67 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $27,768 | 1,903 | 54.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,792 | 38 | 42.5% |
| Unspecified | $672.91 | 1 | 1.3% |
| Travel and Lodging | $559.94 | 6 | 1.1% |
| Education | $488.67 | 7 | 1.0% |
| Grant | $43.95 | 1 | 0.1% |
Payments by Type
General
$50,653
1,955 transactions
Research
$672.91
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $23,229 | 82 | $0 (2024) |
| EMD Serono, Inc. | $2,591 | 279 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,246 | 252 | $0 (2024) |
| ABBVIE INC. | $1,956 | 131 | $0 (2024) |
| Biogen, Inc. | $1,901 | 112 | $0 (2024) |
| UCB, Inc. | $1,530 | 89 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,203 | 75 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $1,138 | 29 | $0 (2019) |
| Lundbeck LLC | $1,033 | 53 | $0 (2024) |
| Allergan, Inc. | $1,031 | 72 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,183 | 277 | ABBVIE INC. ($479.02) |
| 2023 | $5,025 | 271 | ABBVIE INC. ($494.61) |
| 2022 | $9,589 | 242 | Lilly USA, LLC ($5,989) |
| 2021 | $8,146 | 215 | Lilly USA, LLC ($5,467) |
| 2020 | $13,461 | 219 | Lilly USA, LLC ($11,281) |
| 2019 | $3,181 | 243 | EMD Serono, Inc. ($562.15) |
| 2018 | $2,854 | 238 | Teva Pharmaceuticals USA, Inc. ($352.40) |
| 2017 | $3,888 | 251 | Teva Pharmaceuticals USA, Inc. ($832.68) |
All Payment Transactions
1,956 individual payment records from CMS Open Payments — Page 1 of 79
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neuroscience | ||||||
| 12/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.42 | General |
| 12/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $33.85 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.32 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.87 | General |
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Neurology | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: PAIN | ||||||
| 12/06/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: EPILEPSY | ||||||
| 12/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| 12/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $4.20 | General |
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: RETT SYNDROME | ||||||
| 11/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED PARALLEL GROUP, PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF H.P. ACTHAR? GEL IN THE SUBJECTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS | Mallinckrodt LLC | $672.91 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,672 | 39,965 | $1.9M | $464,210 |
| 2022 | 33 | 1,772 | 36,710 | $2.0M | $509,436 |
| 2021 | 35 | 1,802 | 28,891 | $1.3M | $311,563 |
| 2020 | 36 | 1,800 | 19,259 | $1.1M | $230,544 |
Total Patients
7,046
Total Services
124,825
Medicare Billing
$1.5M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3032 | Injection, eptinezumab-jjmr, 1 mg | Office | 2023 | 48 | 17,700 | $926,595 | $234,299 | 25.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 30 | 18,295 | $173,803 | $79,736 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 379 | 527 | $250,325 | $43,427 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 320 | 395 | $98,750 | $22,496 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $42,416 | $10,626 | 25.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 59 | 59 | $33,748 | $7,247 | 21.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $29,184 | $6,680 | 22.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 33 | 144 | $17,712 | $6,539 | 36.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 25 | 65 | $28,665 | $5,802 | 20.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 17 | 17 | $28,900 | $5,343 | 18.5% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 100 | 127 | $21,209 | $4,954 | 23.4% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 53 | 54 | $67,500 | $4,651 | 6.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 59 | 103 | $21,630 | $4,597 | 21.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 61 | 62 | $21,700 | $3,931 | 18.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 26 | 26 | $17,784 | $3,800 | 21.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 39 | 39 | $22,581 | $3,148 | 13.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 19 | 27 | $16,200 | $2,262 | 14.0% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 18 | 18 | $25,632 | $2,212 | 8.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 13 | 37 | $7,807 | $1,920 | 24.6% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 23 | 23 | $8,372 | $1,800 | 21.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 50 | $5,000 | $1,686 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $6,300 | $1,523 | 24.2% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 13 | $3,419 | $1,276 | 37.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 28 | $3,528 | $1,152 | 32.6% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 14 | 14 | $17,300 | $944.44 | 5.5% |
About Dr. Robert Macgregor, M.D
Dr. Robert Macgregor, M.D is a Neurology healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922201912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Macgregor, M.D has received a total of $51,325 in payments from pharmaceutical and medical device companies, with $5,183 received in 2024. These payments were reported across 1,956 transactions from 82 companies. The most common payment nature is "Food and Beverage" ($27,768).
As a Medicare-enrolled provider, Macgregor has provided services to 7,046 Medicare beneficiaries, totaling 124,825 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Savannah, GA
- Active Since 06/07/2007
- Last Updated 07/18/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1922201912
Products in Payments
- EMGALITY (Drug) $17,835
- REYVOW (Drug) $4,240
- ACTHAR (Biological) $2,033
- TYSABRI (Biological) $1,220
- BOTOX (Biological) $1,065
- UBRELVY (Drug) $983.44
- NURTEC ODT (Drug) $809.54
- Briviact (Drug) $641.65
- VYEPTI (Biological) $622.77
- KESIMPTA (Drug) $596.46
- COPAXONE (Drug) $571.28
- VALTOCO (Drug) $502.56
- Fycompa (Drug) $495.04
- Mavenclad (Biological) $481.34
- Vimpat (Drug) $438.82
- Aimovig (Biological) $434.76
- Mavenclad (Drug) $421.49
- QULIPTA (Drug) $418.60
- GILENYA (Drug) $416.61
- INGREZZA (Drug) $376.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Savannah
Victor Rosenfeld, M.d, M.D
Neurology — Payments: $413,963
Neurology $413,963
Dr. Brandi Fleenor, Md, MD
Neurology — Payments: $45,288
Neurology $45,288
Dr. Joel Greenberg, M.d, M.D
Neurology — Payments: $38,325
Neurology $38,325
Stephen Donahue, Md, MD
Neurology — Payments: $26,870
Neurology $26,870
Dr. James Sutton, M.d, M.D
Neurology — Payments: $18,745
Neurology $18,745
Jay Schecter, Md, MD
Neurology — Payments: $17,868
Neurology $17,868